ImmunityBio, Inc.
IBRX$7.71B
Mid CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaSAN DIEGO
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
IBRX News
Catalyst Timeline
0 upcoming, 1 past
No catalysts found.
How IBRX's past catalysts played out
Drug Pipeline
No drugs found in this phase.
Market-Implied Move
Regulatory Approvals
Frequently asked questions
When is ImmunityBio, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for ImmunityBio, Inc. (IBRX) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track IBRX biotech catalysts?→
Add IBRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow ImmunityBio, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply